Literature DB >> 18473163

Hexosaminidase assays.

Michaela Wendeler1, Konrad Sandhoff.   

Abstract

beta-Hexosaminidases (EC 3.2.1.52) are lysosomal enzymes that remove terminal beta-glycosidically bound N-acetylglucosamine and N-acetylgalactosamine residues from a number of glycoconjugates. Reliable assay systems are particularly important for the diagnosis of a family of lysosomal storage disorders, the GM2 gangliosidoses that result from inherited beta-hexosaminidase deficiency. More recently, aberrant hexosaminidase levels have also been found to be associated with a variety of inflammatory diseases. Apart from patient testing and carrier screening, practical in vitro assays are indispensable for the characterization of knock-out mice with potentially altered hexosaminidase activities, for detailed structure-function studies aimed at elucidating the enzymatic mechanism, and to characterize newly described enzyme variants from other organisms. The purpose of this article is to discuss convenient hexosaminidase assay procedures for these and other applications, using fluorogenic or chromogenic artificial substrates as well as the physiological glycolipid substrate GM2. Attempts are also made to provide an overview of less commonly used alternative techniques and to introduce recent developments enabling high-throughput screening for enzyme inhibitors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18473163     DOI: 10.1007/s10719-008-9137-5

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  70 in total

1.  The hydrolysis of Tay-Sachs ganglioside (TSG) by human N-acetyl-beta-D-hexosaminidase A.

Authors:  K Sandhoff
Journal:  FEBS Lett       Date:  1970-12-18       Impact factor: 4.124

2.  Towards quality assurance in the determination of lysosomal enzymes: a two-centre study.

Authors:  Z Lukacs; A Keil; V Peters; A Kohlschütter; G F Hoffmann; M Cantz; J Kopitz
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

3.  Thermodynamic study of beta-N-acetylhexosaminidase enzyme heterogeneity in human seminal plasma.

Authors:  J Antonio Casal; Luis Vizcaíno; Jesús Garcia-Devesa; J Carlos Tutor
Journal:  Clin Chim Acta       Date:  2005-05       Impact factor: 3.786

4.  Optimization of an enzymatic method for the determination of lysosomal N-acetyl-beta-D-hexosaminidase and beta-glucuronidase in synovial fluid.

Authors:  Justyna Marciniak; Anna Zalewska; Janusz Popko; Krzysztof Zwierz
Journal:  Clin Chem Lab Med       Date:  2006       Impact factor: 3.694

5.  Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate.

Authors:  M Potier; L Mameli; M Bélisle; L Dallaire; S B Melançon
Journal:  Anal Biochem       Date:  1979-04-15       Impact factor: 3.365

Review 6.  Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids.

Authors:  Thomas Kolter; Konrad Sandhoff
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

7.  The X-ray crystal structure of human beta-hexosaminidase B provides new insights into Sandhoff disease.

Authors:  Timm Maier; Norbert Strater; Christina G Schuette; Ralf Klingenstein; Konrad Sandhoff; Wolfram Saenger
Journal:  J Mol Biol       Date:  2003-05-02       Impact factor: 5.469

8.  High-throughput screening for human lysosomal beta-N-Acetyl hexosaminidase inhibitors acting as pharmacological chaperones.

Authors:  Michael B Tropak; Jan E Blanchard; Stephen G Withers; Eric D Brown; Don Mahuran
Journal:  Chem Biol       Date:  2007-02

9.  A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder.

Authors:  Y Liu; R Wada; H Kawai; K Sango; C Deng; T Tai; M P McDonald; K Araujo; J N Crawley; U Bierfreund; K Sandhoff; K Suzuki; R L Proia
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

10.  First-trimester prenatal diagnosis of Tay-Sachs disease.

Authors:  G A Grabowski; J R Kruse; J D Goldberg; K Chockkalingam; R E Gordon; K J Blakemore; M J Mahoney; R J Desnick
Journal:  Am J Hum Genet       Date:  1984-11       Impact factor: 11.025

View more
  34 in total

1.  Clinical, biochemical and mutation profile in Indian patients with Sandhoff disease.

Authors:  Parag M Tamhankar; Mehul Mistri; Pratima Kondurkar; Daksha Sanghavi; Jayesh Sheth
Journal:  J Hum Genet       Date:  2015-11-19       Impact factor: 3.172

2.  Analysis of the bioactivity of magnetically immunoisolated peroxisomes.

Authors:  Yaohua Wang; Thane H Taylor; Edgar A Arriaga
Journal:  Anal Bioanal Chem       Date:  2011-11-08       Impact factor: 4.142

3.  Intrathecal gene therapy corrects CNS pathology in a feline model of mucopolysaccharidosis I.

Authors:  Christian Hinderer; Peter Bell; Brittney L Gurda; Qiang Wang; Jean-Pierre Louboutin; Yanqing Zhu; Jessica Bagel; Patricia O'Donnell; Tracey Sikora; Therese Ruane; Ping Wang; Mark E Haskins; James M Wilson
Journal:  Mol Ther       Date:  2014-07-16       Impact factor: 11.454

4.  Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99).

Authors:  Ying Jiang; Yutaka Sato; Eunju Im; Martin Berg; Matteo Bordi; Sandipkumar Darji; Asok Kumar; Panaiyur S Mohan; Urmi Bandyopadhyay; Antonio Diaz; Ana Maria Cuervo; Ralph A Nixon
Journal:  J Neurosci       Date:  2019-05-01       Impact factor: 6.167

5.  Brain endothelial specific gene therapy improves experimental Sandhoff disease.

Authors:  Godwin Dogbevia; Hanna Grasshoff; Alaa Othman; Anke Penno; Markus Schwaninger
Journal:  J Cereb Blood Flow Metab       Date:  2019-07-29       Impact factor: 6.200

6.  Development of Unsymmetrical Dyads As Potent Noncarbohydrate-Based Inhibitors against Human β-N-Acetyl-d-hexosaminidase.

Authors:  Peng Guo; Qi Chen; Tian Liu; Lin Xu; Qing Yang; Xuhong Qian
Journal:  ACS Med Chem Lett       Date:  2013-04-24       Impact factor: 4.345

7.  Proteomic analysis of mouse models of Niemann-Pick C disease reveals alterations in the steady-state levels of lysosomal proteins within the brain.

Authors:  David E Sleat; Jennifer A Wiseman; Istvan Sohar; Mukarram El-Banna; Haiyan Zheng; Dirk F Moore; Peter Lobel
Journal:  Proteomics       Date:  2012-11-22       Impact factor: 3.984

8.  Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation.

Authors:  Dan Wang; Charu Shukla; Xiaoli Liu; Trenton R Schoeb; Lorne A Clarke; David M Bedwell; Kim M Keeling
Journal:  Mol Genet Metab       Date:  2010-01       Impact factor: 4.797

9.  Investigation of Polyethylenimine/DNA Polyplex Transfection to Cultured Cells Using Radiolabeling and Subcellular Fractionation Methods.

Authors:  Julie Shi; Brian Chou; Jennifer L Choi; Anh L Ta; Suzie H Pun
Journal:  Mol Pharm       Date:  2013-03-05       Impact factor: 4.939

10.  Efficient and Regioselective Synthesis of β-GalNAc/GlcNAc-Lactose by a Bifunctional Transglycosylating β-N-Acetylhexosaminidase from Bifidobacterium bifidum.

Authors:  Xiaodi Chen; Li Xu; Lan Jin; Bin Sun; Guofeng Gu; Lili Lu; Min Xiao
Journal:  Appl Environ Microbiol       Date:  2016-08-30       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.